Stockscreener 앱 받기
6.54
2.24%
-0.15
시간 외 거래:
6.60
0.06
+0.92%
전일 마감가:
$6.69
열려 있는:
$6.69
하루 거래량:
3.37M
Relative Volume:
1.45
시가총액:
$652.19M
수익:
$58.36M
순이익/손실:
$-25.72M
주가수익비율:
-17.96
EPS:
-0.3641
순현금흐름:
$-24.91M
1주 성능:
+12.76%
1개월 성능:
+34.02%
6개월 성능:
+170.25%
1년 성능:
+39.15%
1일 변동 폭
$6.395
$6.73
1주일 범위
$5.78
$6.865
52주 변동 폭
$2.12
$6.865
Aquestive Therapeutics Inc Stock (AQST) Company Profile
명칭
Aquestive Therapeutics Inc
전화
908-941-1900
주소
30 TECHNOLOGY DRIVE, WARREN, NJ
AQST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AQST
Aquestive Therapeutics Inc
|
6.54 | 809.31M | 58.36M | -25.72M | -24.91M | -0.3641 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | Oppenheimer | Outperform |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-05-10 | 개시 | Leerink Partners | Outperform |
| 2024-04-11 | 개시 | Piper Sandler | Overweight |
| 2024-03-28 | 개시 | Raymond James | Outperform |
| 2021-04-07 | 재개 | RBC Capital Mkts | Outperform |
| 2019-04-22 | 개시 | H.C. Wainwright | Buy |
| 2019-01-03 | 개시 | Lake Street | Buy |
| 2018-08-20 | 개시 | JMP Securities | Mkt Outperform |
| 2018-08-20 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Aquestive Therapeutics Inc 주식(AQST)의 최신 뉴스
Aquestive Therapeutics (AQST) Surges 7.9%: Is This an Indication of Further Gains? - Yahoo Finance
Is Aquestive Therapeutics Inc. reversing from oversold territoryJuly 2025 EndofMonth & Reliable Trade Execution Plans - newser.com
How to build a dashboard for Aquestive Therapeutics Inc. stockStock Surge & Momentum Based Trading Signals - newser.com
Weiss Ratings Reiterates Sell (D-) Rating for Aquestive Therapeutics (NASDAQ:AQST) - MarketBeat
JMP Securities Maintains Aquestive Therapeutics (AQST) Market Outperform Recommendation - Nasdaq
What high frequency data says about Aquestive Therapeutics Inc.July 2025 Trends & Free Weekly Chart Analysis and Trade Guides - newser.com
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™ - GlobeNewswire
Aquestive Therapeutics Shares Rise After Obtaining 2 New US Patents for Anaphylm Sublingual Film - MarketScreener
Aquestive Therapeutics Obtains 2 New US Patents for Anaphylm Sublingual Film - MarketScreener
Aquestive receives two new patents for oral anaphylaxis treatment By Investing.com - Investing.com Nigeria
Aquestive receives two new patents for oral anaphylaxis treatment - Investing.com India
Aquestive Therapeutics Broadens Patent Estate for Anaphylm™ - GlobeNewswire Inc.
Signal strength of Aquestive Therapeutics Inc. stock in tech scanners2025 Technical Patterns & Safe Capital Growth Trade Ideas - newser.com
Why Aquestive Therapeutics Inc. stock is seen as undervaluedWeekly Profit Summary & Community Verified Watchlist Alerts - newser.com
Custom watchlist performance reports with Aquestive Therapeutics Inc.2025 Dividend Review & Free Expert Verified Stock Movement Alerts - newser.com
Statistical indicators supporting Aquestive Therapeutics Inc.’s strengthTrade Analysis Summary & Comprehensive Market Scan Insights - newser.com
Advanced analytics toolkit walkthrough for Aquestive Therapeutics Inc.Portfolio Profit Report & AI Forecast for Swing Trade Picks - newser.com
Aquestive Therapeutics Advances Anaphylm Clinical Development - TipRanks
Aquestive Therapeutics SVP sells $63,000 in shares By Investing.com - Investing.com Nigeria
Aquestive Therapeutics CEO Barber sells $551k in shares By Investing.com - Investing.com Canada
Aquestive Therapeutics (NASDAQ:AQST) CEO Sells $550,798.29 in Stock - MarketBeat
Peter Boyd Sells 10,000 Shares of Aquestive Therapeutics (NASDAQ:AQST) Stock - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Trading Down 5.3% After Insider Selling - MarketBeat
Aquestive Therapeutics SVP sells $63,000 in shares - Investing.com
Aquestive Therapeutics Hits New 52-Week High of $6.00, Up 105.43% - Markets Mojo
What drives Aquestive Therapeutics Inc stock priceAI-Driven Market Analysis & Master Stock Selection - earlytimes.in
Aquestive Therapeutics Hits New 52-Week High of $6.43 - Markets Mojo
Is Aquestive Therapeutics Inc a good long term investmentSmall Cap Stock Opportunities & Collaborate and Win Together - earlytimes.in
What analysts say about Aquestive Therapeutics Inc stockVolume Weighted Average Price & See Risk Factors Before Making Any Move - earlytimes.in
Published on: 2025-09-28 19:22:53 - earlytimes.in
Aquestive Therapeutics Sees Stock Surge Following FDA Approval News - timothysykes.com
AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDA - MSN
Aquestive Therapeutics Inc (AQST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Aquestive Therapeutics Inc 주식 (AQST) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Boyd Peter E. | See Remarks |
Sep 26 '25 |
Sale |
6.30 |
10,000 |
63,000 |
278,323 |
1.54%
1.20%
자본화:
|
볼륨(24시간):